-
4
-
-
34247569300
-
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California cancer Registry
-
K.R. Bauer, M. Brown, R.D. Cress, C.A. Parise, and V. Caggiano Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry Cancer 109 2007 1721 1728
-
(2007)
Cancer
, vol.109
, pp. 1721-1728
-
-
Bauer, K.R.1
Brown, M.2
Cress, R.D.3
Parise, C.A.4
Caggiano, V.5
-
5
-
-
34547661993
-
Triple-negative breast cancer: Clinical features and patterns of recurrence
-
R. Dent, M. Trudeau, and K.I. Pritchard Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 15 pt 1 2007 4429 4434
-
(2007)
Clin Cancer Res
, vol.13
, Issue.15
, pp. 4429-4434
-
-
Dent, R.1
Trudeau, M.2
Pritchard, K.I.3
-
6
-
-
37248999372
-
Triple-negative tumors: A critical review
-
J.S. Reis-Filho, and A.N.J. Tutt Triple-negative tumors: a critical review Histopathology 52 1 2008 108 118
-
(2008)
Histopathology
, vol.52
, Issue.1
, pp. 108-118
-
-
Reis-Filho, J.S.1
Tutt, A.N.J.2
-
7
-
-
79551649114
-
Basal-like and triple-negative breast cancers: A critical review with an emphasis on the implications for pathologists and oncologists
-
Sunil Badve, David J. Dabbs, Stuart J. Schnitt, Frederick L. Baehner, Thomas Decker, and Vincenzo Eusebi Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists Mod Pathol 24 2011 157 167
-
(2011)
Mod Pathol
, vol.24
, pp. 157-167
-
-
Badve, S.1
Dabbs, D.J.2
Schnitt, S.J.3
Baehner, F.L.4
Decker, T.5
Eusebi, V.6
-
8
-
-
84890283025
-
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
-
[PMID: 24114677 [PubMed - indexed for MEDLINE]]
-
B.D. Lehmann, and J.A. Pietenpol Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes J Pathol 232 2014 142 150 [PMID: 24114677 [PubMed - indexed for MEDLINE]]
-
(2014)
J Pathol
, vol.232
, pp. 142-150
-
-
Lehmann, B.D.1
Pietenpol, J.A.2
-
9
-
-
34248595234
-
Ki-67 as prognostic marker in early breast cancer: A meta-analysis of published studies involving 12,155 patients
-
E. De Azambuja, F. Cardoso, and G. de Castro Jr. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients Br J Cancer 96 2007 1504 1513
-
(2007)
Br J Cancer
, vol.96
, pp. 1504-1513
-
-
De Azambuja, E.1
Cardoso, F.2
De Castro, Jr.G.3
-
10
-
-
33847127375
-
The claudin gene family: Expression in normal and neoplastic tissues
-
K.J. Hewitt, R. Agarwal, and P.J. Morin The claudin gene family: expression in normal and neoplastic tissues BMC Cancer 6 2006 186 10.1186/1471-2407-6-186
-
(2006)
BMC Cancer
, vol.6
, pp. 186
-
-
Hewitt, K.J.1
Agarwal, R.2
Morin, P.J.3
-
11
-
-
81855194325
-
Identification of a claudin-4 and E-cadherin score to predict prognosis in breast cancer
-
A.M. Szasz, Z. Nemeth, and B. Gyorffy Identification of a claudin-4 and E-cadherin score to predict prognosis in breast cancer Jpn Cancer Assoc 102 2011 2248 2254 10.1111/j.1349-7006.2011.02085
-
(2011)
Jpn Cancer Assoc
, vol.102
, pp. 2248-2254
-
-
Szasz, A.M.1
Nemeth, Z.2
Gyorffy, B.3
-
12
-
-
33644770016
-
Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions
-
S.C. Cunningham, F. Kamangar, M.P. Kim, S. Hammoud, R. Haque, and C.A. Iacobuzio-Donahue Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions Cancer Epidemiol Biomarkers Prev 15 2006 281 287
-
(2006)
Cancer Epidemiol Biomarkers Prev
, vol.15
, pp. 281-287
-
-
Cunningham, S.C.1
Kamangar, F.2
Kim, M.P.3
Hammoud, S.4
Haque, R.5
Iacobuzio-Donahue, C.A.6
-
13
-
-
0942266005
-
Claudin 4 Protein Expression in Primary and Metastatic Pancreatic Cancer
-
Lynette S. Nichols, Raheela Ashfaq, and Christine A. Iacobuzio-Donahue Claudin 4 Protein Expression in Primary and Metastatic Pancreatic Cancer Am J Clin Pathol 121 2004 226 230
-
(2004)
Am J Clin Pathol
, vol.121
, pp. 226-230
-
-
Nichols, L.S.1
Ashfaq, R.2
Iacobuzio-Donahue, C.A.3
-
14
-
-
33947148570
-
Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas
-
G.M. Sheehan, B.V. Kallakury, C.E. Sheehan, H.A. Fisher, R.P. Kaufman Jr., and J.S. Ross Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas Hum Pathol 38 2007 564 569
-
(2007)
Hum Pathol
, vol.38
, pp. 564-569
-
-
Sheehan, G.M.1
Kallakury, B.V.2
Sheehan, C.E.3
Fisher, H.A.4
Kaufman, Jr.R.P.5
Ross, J.S.6
-
15
-
-
42749097342
-
Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer
-
G.E. Konecny, R. Agarwal, G.A. Keeney, B. Winterhoff, M.B. Jones, and A. Mariani Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer Gynecol Oncol 109 2008 263 269
-
(2008)
Gynecol Oncol
, vol.109
, pp. 263-269
-
-
Konecny, G.E.1
Agarwal, R.2
Keeney, G.A.3
Winterhoff, B.4
Jones, M.B.5
Mariani, A.6
-
16
-
-
18444417781
-
Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: A research study
-
A.M. Tokés, J. Kulka, and S. Paku Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study Breast Cancer Res 7 2005 R296 R305
-
(2005)
Breast Cancer Res
, vol.7
, pp. R296-R305
-
-
Tokés, A.M.1
Kulka, J.2
Paku, S.3
-
17
-
-
78049308800
-
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
-
A. Prat, J. Parker, and O. Karginova Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Breast Cancer Res 12 2010 R68 10.1186/bcr2635
-
(2010)
Breast Cancer Res
, vol.12
, pp. R68
-
-
Prat, A.1
Parker, J.2
Karginova, O.3
-
18
-
-
84869442301
-
Clinicopathologic features of molecular subtypes of triple negative breast cancer based on immunohistochemical markers
-
[PMID: 23018247 [PubMed - indexed for MEDLINE]]
-
J. Choi, W.H. Jung, and J.S. Koo Clinicopathologic features of molecular subtypes of triple negative breast cancer based on immunohistochemical markers Histol Histopathol 27 11 2012 1481 1493 [PMID: 23018247 [PubMed - indexed for MEDLINE]]
-
(2012)
Histol Histopathol
, vol.27
, Issue.11
, pp. 1481-1493
-
-
Choi, J.1
Jung, W.H.2
Koo, J.S.3
-
19
-
-
84867550136
-
Claudin expression in breast cancer: High or low, what to expect?
-
[PMID: 22936447 [PubMed - indexed for MEDLINE]]
-
S. Ricardo, R. Gerhard, and J.F. Cameselle-Teijeiro Claudin expression in breast cancer: high or low, what to expect? Histol Histopathol 27 10 2012 1283 1295 [PMID: 22936447 [PubMed - indexed for MEDLINE]]
-
(2012)
Histol Histopathol
, vol.27
, Issue.10
, pp. 1283-1295
-
-
Ricardo, S.1
Gerhard, R.2
Cameselle-Teijeiro, J.F.3
-
20
-
-
84855263756
-
Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer
-
[PMID: 21956537 [PubMed - indexed for MEDLINE]]
-
M.A. Bernardi, A.F. Logullo, and F.S. Pasini Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer Oncol Rep 27 2012 28 38 [PMID: 21956537 [PubMed - indexed for MEDLINE]]
-
(2012)
Oncol Rep
, vol.27
, pp. 28-38
-
-
Bernardi, M.A.1
Logullo, A.F.2
Pasini, F.S.3
-
21
-
-
1842472276
-
Mechanisms of androgen receptor signaling via steroid receptor coactivator-1 in prostate
-
S.M. Powell, V. Christiaens, and D. Voulgaraki Mechanisms of androgen receptor signaling via steroid receptor coactivator-1 in prostate Endocr Relat Cancer 11 2004 117 130
-
(2004)
Endocr Relat Cancer
, vol.11
, pp. 117-130
-
-
Powell, S.M.1
Christiaens, V.2
Voulgaraki, D.3
-
22
-
-
44949129660
-
Androgen receptor expression in breast cancer: Relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors
-
L.O. Gonzalez, M.D. Corte, and J. Vazquez Androgen receptor expression in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors BMC Cancer 8 2008 149 10.1186/1471-2407-8-149
-
(2008)
BMC Cancer
, vol.8
, pp. 149
-
-
Gonzalez, L.O.1
Corte, M.D.2
Vazquez, J.3
-
23
-
-
68049128114
-
Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer
-
A.A. Peters, G. Buchanan, and C. Ricciardelli Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer Cancer Res 69 2009 6131 6140
-
(2009)
Cancer Res
, vol.69
, pp. 6131-6140
-
-
Peters, A.A.1
Buchanan, G.2
Ricciardelli, C.3
-
24
-
-
84891752262
-
The impact of androgen receptor expression on breast cancer survival: A retrospective study and metanalysis
-
Q. Qu, Y. Mao, X.-c. Fei, and K.-w. Shen The impact of androgen receptor expression on breast cancer survival: a retrospective study and metanalysis PLoS One 8 2013 12 20 10.1371/journal.pone.0082650 [ www.plosone.org ]
-
(2013)
PLoS One
, vol.8
, pp. 12-20
-
-
Qu, Q.1
Mao, Y.2
Fei, X.-C.3
Shen, K.-W.4
-
25
-
-
79960989401
-
Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
-
S. Park, J.S. Koo, and M.S. Kim Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers Ann Oncol 22 2011 1755 1762
-
(2011)
Ann Oncol
, vol.22
, pp. 1755-1762
-
-
Park, S.1
Koo, J.S.2
Kim, M.S.3
-
26
-
-
84880379664
-
The role of androgen receptor in triple negative breast cancer
-
P.D. Shah, A. Gucalp, and T.A. Traina The role of androgen receptor in triple negative breast cancer Womens Health (Lond Engl) 9 4 2013 351 360
-
(2013)
Womens Health (Lond Engl)
, vol.9
, Issue.4
, pp. 351-360
-
-
Shah, P.D.1
Gucalp, A.2
Traina, T.A.3
-
29
-
-
84867024734
-
Decreased Androgen Receptor Expression is Associated with Distant Metastases in Patients with Androgen Receptor-Expressing Triple-Negative Breast Carcinoma
-
L.M. Sutton, D. Cao, V. Sarode, K.H. Molberg, K. Torgbe, and B. Haley Decreased Androgen Receptor Expression Is Associated With Distant Metastases in Patients With Androgen Receptor-Expressing Triple-Negative Breast Carcinoma Am J Clin Pathol 138 2012 511 516 10.1309/AJCP8AVF8FDPTZLH
-
(2012)
Am J Clin Pathol
, vol.138
, pp. 511-516
-
-
Sutton, L.M.1
Cao, D.2
Sarode, V.3
Molberg, K.H.4
Torgbe, K.5
Haley, B.6
-
30
-
-
68249144780
-
Breast cancer subtypes based on ER/PR and Her2 expression: Comparison of clinicopathologic features and survival
-
A.A. Onitilo, J.M. Engel, R.T. Greenlee, and B.N. Mukesh Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival Clin Med Res 7 1-2 2009 4 13
-
(2009)
Clin Med Res
, vol.7
, Issue.12
, pp. 4-13
-
-
Onitilo, A.A.1
Engel, J.M.2
Greenlee, R.T.3
Mukesh, B.N.4
-
31
-
-
33646198056
-
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status
-
M. Dowsett, J. Houghton, and C. Iden Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status Ann Oncol 17 2006 818 826
-
(2006)
Ann Oncol
, vol.17
, pp. 818-826
-
-
Dowsett, M.1
Houghton, J.2
Iden, C.3
-
32
-
-
41649102048
-
Response to neoadjuvant therapy and long-term survival in patients with triple negative breast cancer
-
C. Liedtke, C. Mazouni, K.R. Hess, F. Andre, A. Tordai, and J.A. Mejia Response to neoadjuvant therapy and long-term survival in patients with triple negative breast cancer J Clin Oncol 26 2008 1275 1281
-
(2008)
J Clin Oncol
, vol.26
, pp. 1275-1281
-
-
Liedtke, C.1
Mazouni, C.2
Hess, K.R.3
Andre, F.4
Tordai, A.5
Mejia, J.A.6
-
33
-
-
84876495804
-
Claudin expression in high-grade invasive ductal carcinoma of the breast: Correlation with the molecular subtype
-
[ ]
-
S. Lu, K. Singh, S. Mangray, R. Tavares, L. Noble, and M.B. Resnick Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype Mod Pathol 26 2013 485 495 [ www.modernpathology.org ]
-
(2013)
Mod Pathol
, vol.26
, pp. 485-495
-
-
Lu, S.1
Singh, K.2
Mangray, S.3
Tavares, R.4
Noble, L.5
Resnick, M.B.6
-
34
-
-
10944258685
-
Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma
-
Y. Soini Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma Hum Pathol 35 2004 1531 1536
-
(2004)
Hum Pathol
, vol.35
, pp. 1531-1536
-
-
Soini, Y.1
-
35
-
-
63449095110
-
Increased claudin-4 expression is associated with poor prognosis and high tumor grade in breast cancer
-
F. Lanigan, E. McKiernan, and D.J. Brennan Increased claudin-4 expression is associated with poor prognosis and high tumor grade in breast cancer Int J Cancer 124 2009 2088 2097
-
(2009)
Int J Cancer
, vol.124
, pp. 2088-2097
-
-
Lanigan, F.1
McKiernan, E.2
Brennan, D.J.3
-
36
-
-
67649111981
-
Claudins-1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype
-
A.A. Blanchard, G.P. Skliris, and P.H. Watson Claudins-1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype Virchows Arch 454 2009 647 656
-
(2009)
Virchows Arch
, vol.454
, pp. 647-656
-
-
Blanchard, A.A.1
Skliris, G.P.2
Watson, P.H.3
-
37
-
-
67749093433
-
Expression of tight junction protein claudin-4 in basal-like breast carcinomas
-
[PMID: 18752049 [PubMed - indexed for MEDLINE]]
-
J. Kulka, A.M. Szasz, and Z. Nemeth Expression of tight junction protein claudin-4 in basal-like breast carcinomas Pathol Oncol Res 15 2009 59 64 [PMID: 18752049 [PubMed - indexed for MEDLINE]]
-
(2009)
Pathol Oncol Res
, vol.15
, pp. 59-64
-
-
Kulka, J.1
Szasz, A.M.2
Nemeth, Z.3
-
38
-
-
84896691003
-
Claudin-3 and claudin-4: Distinct prognostic significance in triple-negative and luminal breast cancer
-
[PMID: 23702644 [PubMed - in process]]
-
P. Kolokytha, P. Yiannou, and D. Keramopoulos Claudin-3 and claudin-4: distinct prognostic significance in triple-negative and luminal breast cancer Appl Immunohistochem Mol Morphol 22 2 2014 125 131 10.1097/PAI.0b013e31828d9d62 [PMID: 23702644 [PubMed - in process]]
-
(2014)
Appl Immunohistochem Mol Morphol
, vol.22
, Issue.2
, pp. 125-131
-
-
Kolokytha, P.1
Yiannou, P.2
Keramopoulos, D.3
-
39
-
-
0242300581
-
Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations
-
S.N. Agoff, P.E. Swanson, and H. Linden Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations Am J Clin Pathol 120 2003 725 731
-
(2003)
Am J Clin Pathol
, vol.120
, pp. 725-731
-
-
Agoff, S.N.1
Swanson, P.E.2
Linden, H.3
-
40
-
-
77449140006
-
Androgens and the breast
-
C. Dimitrakakis, and C. Bondy Androgens and the breast Breast Cancer Res 11 5 2009 212 221 10.1186/bcr2413
-
(2009)
Breast Cancer Res
, vol.11
, Issue.5
, pp. 212-221
-
-
Dimitrakakis, C.1
Bondy, C.2
-
41
-
-
77649188673
-
Expression of androgen receptors in primary breast Cancer
-
S. Park, J. Koo, H.S. Park, J.-H. Kim, S.-Y. Choi, and J.H. Lee Expression of androgen receptors in primary breast Cancer Ann Oncol 21 2010 488 492 10.1093/annonc/mdp510
-
(2010)
Ann Oncol
, vol.21
, pp. 488-492
-
-
Park, S.1
Koo, J.2
Park, H.S.3
Kim, J.-H.4
Choi, S.-Y.5
Lee, J.H.6
-
42
-
-
27244443082
-
Proliferation marker Ki-67 in early breast cancer
-
A. Urruticoechea, I.E. Smith, and M. Dowsett Proliferation marker Ki-67 in early breast cancer J Clin Oncol 2005 23 2005 7212 7220
-
(2005)
J Clin Oncol
, vol.2005
, Issue.23
, pp. 7212-7220
-
-
Urruticoechea, A.1
Smith, I.E.2
Dowsett, M.3
-
43
-
-
44949151486
-
Anti-proliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors
-
E.J. Cops, T. Bianco-Miotto, and N.L. Moore Anti-proliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors J Steroid Biochem Mol Biol 110 2008 236 243
-
(2008)
J Steroid Biochem Mol Biol
, vol.110
, pp. 236-243
-
-
Cops, E.J.1
Bianco-Miotto, T.2
Moore, N.L.3
-
44
-
-
79959998479
-
Androgen receptor expression in breast cancer in relation to molecular phenotype: Results from the Nurses' Health Study
-
L.C. Collins, K.S. Cole, and J.D. Marotti Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study Mod Pathol 24 2011 924 931
-
(2011)
Mod Pathol
, vol.24
, pp. 924-931
-
-
Collins, L.C.1
Cole, K.S.2
Marotti, J.D.3
|